News | June 11, 2018

Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 11, 2018– Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key...

News | May 24, 2018

Iterum Therapeutics Announces Pricing of Initial Public Offering DUBLIN and CHICAGO, May 24, 2018 /PRNewswire/ — Iterum Therapeutics plc (NASDAQ:ITRM), a clinical-stage pharmaceutical company developing anti-infectives aimed at combatting the global crisis of...

News | June 12, 2018

Truveris Expands Audit Capabilities with Launch of TruAuditâ„¢ Solution allows clients to track PBM performance by implementing several new audits NEW YORK–(BUSINESS WIRE)–Truveris, Inc. today announced new audit capabilities geared towards further...

News | May 5, 2018

NeuroStar® Advanced Therapy Reaches Monumental Milestone of 1.7 Million Treatments in the US Non-drug, non-invasive NeuroStar has become a mainstream option for depression patients, and is now covered by most insurance companies and available in 49 states MALVERN,...

News | June 2, 2018

Deciphera Pharmaceuticals Reports Updated Interim Phase 1 Clinical Study Results with DCC-2618 at The 2018 American Society of Clinical Oncology Annual Meeting (ASCO) and Provides Additional Clinical and Regulatory Updates on DCC-2618 – Initial Objective...
nunc lectus facilisis neque. velit, Praesent pulvinar sed felis quis mattis